This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Areas
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
learning zone banner

Ophthalmology Learning Zone

View more
Bayer Ophthalmology Masterclass Programme
Interactive meetings and online resources to refresh your knowledge
PP-EYL-GB-2858, March 2026

Oncology Learning Zone

View more
Request An Interactive Pharmacist’s Guide
NUBEQA® (darolutamide)
PP-NUB-GB-2388, May 2025
NUBEQA® (darolutamide) Drug-Drug Interactions Learning Guide
PP-NUB-GB-2129, March 2025
Module 4: MI Course
Xofigo®▼ (radium-223 dichloride) | NUBEQA® (darolutamide)
RP-NUB-GB-0713, January 2025
Module 3: MI Course
Xofigo®▼ (radium-223 dichloride) | NUBEQA® (darolutamide)
RP-NUB-GB-0712, January 2025

Women's Health Learning Zone

View more
Urogenital Symptoms and Sexual Difficulties
(5 mins) Often underreported and undertreated symptoms that significantly affect a woman's relationships.
PP-PF-WHC-IUS-GB-0085 October 2024
Musculoskeletal Symptoms, Anxiety, Low Mood and Brain Fog
(4 mins) Causes for musculoskeletal (MSK) symptoms, how menopause can worsen existing anxiety and depression.
PP-PF-WHC-IUS-GB-0084 October 2024
Relationship Between Flushes and Sweats, Sleep and Mood
(4 mins) Vasomotor symptoms (VMS), sleep disturbances, and mood changes are distressing menopause symptoms.
PP-PF-WHC-IUS-GB-0083 October 2024
Menopause and the Workplace
(4 mins) Understand how menopause can impact on women in the workplace and how we may better support them.
PP-PF-WHC-IUS-GB-0097 March 2025